PSNL Personalis, Inc.

Price (delayed)

$25.28

Market cap

$984.22M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.89

Enterprise value

$859.87M

Sector: Healthcare
Industry: Diagnostics & Research
Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.

Highlights

The quick ratio has surged by 130% since the previous quarter and by 112% year-on-year
The equity has soared by 119% QoQ and by 83% YoY
Personalis's EPS has soared by 78% YoY but it has decreased by 6% from the previous quarter
Personalis's net income has plunged by 57% YoY and by 8% from the previous quarter
The gross margin has declined by 20% year-on-year and by 4.9% since the previous quarter

Key stats

What are the main financial stats of PSNL
Market
Shares outstanding
38.93M
Market cap
$984.22M
Enterprise value
$859.87M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.96
Price to sales (P/S)
11.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.22
Earnings
Revenue
$76.63M
EBIT
-$34.54M
EBITDA
-$29.57M
Free cash flow
-$42.04M
Per share
EPS
-$0.89
Free cash flow per share
-$1.19
Book value per share
$6.38
Revenue per share
$2.16
TBVPS
$7.02
Balance sheet
Total assets
$248.81M
Total liabilities
$45.27M
Debt
$8.9M
Equity
$203.54M
Working capital
$187.69M
Liquidity
Debt to equity
0.04
Current ratio
6.23
Quick ratio
5.9
Net debt/EBITDA
4.21
Margins
EBITDA margin
-38.6%
Gross margin
26.9%
Net margin
-45.1%
Operating margin
-46.9%
Efficiency
Return on assets
-19.7%
Return on equity
-27.5%
Return on invested capital
-49.1%
Return on capital employed
-16.2%
Return on sales
-45.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PSNL stock price

How has the Personalis stock price performed over time
Intraday
-3.47%
1 week
-10.13%
1 month
-3.77%
1 year
187.93%
YTD
131.93%
QTD
16.66%

Financial performance

How have Personalis's revenue and profit performed over time
Revenue
$76.63M
Gross profit
$20.61M
Operating income
-$35.97M
Net income
-$34.58M
Gross margin
26.9%
Net margin
-45.1%
PSNL's operating income has dropped by 96% year-on-year and by 12% since the previous quarter
Personalis's net income has plunged by 57% YoY and by 8% from the previous quarter
PSNL's operating margin has shrunk by 54% YoY and by 8% QoQ
PSNL's revenue is up by 27% YoY and by 3.6% QoQ

Growth

What is Personalis's growth rate over time

Valuation

What is Personalis stock price valuation
P/E
N/A
P/B
3.96
P/S
11.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.22
Personalis's EPS has soared by 78% YoY but it has decreased by 6% from the previous quarter
The equity has soared by 119% QoQ and by 83% YoY
The stock's price to book (P/B) is 16% more than its last 4 quarters average of 3.4
The stock's price to sales (P/S) is 109% more than its last 4 quarters average of 5.6
PSNL's revenue is up by 27% YoY and by 3.6% QoQ

Efficiency

How efficient is Personalis business performance
Personalis's return on equity has surged by 96% YoY and by 12% QoQ
Personalis's ROS has decreased by 32% YoY and by 5% from the previous quarter
PSNL's ROIC is up by 15% since the previous quarter
The return on assets is up by 5% since the previous quarter

Dividends

What is PSNL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PSNL.

Financial health

How did Personalis financials performed over time
The quick ratio has surged by 130% since the previous quarter and by 112% year-on-year
The company's current ratio has surged by 123% QoQ and by 110% YoY
The debt is 96% smaller than the equity
The equity has soared by 119% QoQ and by 83% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.